Proteostasis Therapeutics OverviewProteostasis Therapeutics Research & Development
Research & Development expenses for PTI.
Quarterly R&D Expenses
$1.24M
↓ 87.78% YoY
As of Sep 30, 2020
Annual R&D Expenses (TTM)
$21.44M
↓ 62.34% YoY
Trailing 12 months ending Sep 30, 2020